# Recursion Pharmaceuticals, Inc. (RXRX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$648M |
| 2024 | -$479M |
| 2023 | -$350M |
| 2022 | -$246M |
| 2021 | -$183M |
| 2020 | -$85M |
| 2019 | -$62M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$129M |
| 2025-09-30 | -$172M |
| 2025-06-30 | -$176M |
| 2025-03-31 | -$191M |
| 2024-09-30 | -$98M |
| 2024-06-30 | -$101M |
| 2024-03-31 | -$96M |
| 2023-09-30 | -$100M |
| 2023-06-30 | -$82M |
| 2023-03-31 | -$70M |
| 2022-09-30 | -$63M |
| 2022-06-30 | -$66M |
| 2022-03-31 | -$56M |
| 2021-09-30 | -$46M |
| 2021-06-30 | -$41M |
| 2021-03-31 | -$30M |
| 2020-09-30 | -$22M |
| 2020-06-30 | -$18M |
| 2020-03-31 | -$18M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/RXRX/operating-income)